These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 28396669)

  • 1. Basophil Activation-Dependent Autoantibody and Interleukin-17 Production Exacerbate Systemic Lupus Erythematosus.
    Pan Q; Gong L; Xiao H; Feng Y; Li L; Deng Z; Ye L; Zheng J; Dickerson CA; Ye L; An N; Yang C; Liu HF
    Front Immunol; 2017; 8():348. PubMed ID: 28396669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. B cell and/or autoantibody deficiency do not prevent neuropsychiatric disease in murine systemic lupus erythematosus.
    Wen J; Doerner J; Chalmers S; Stock A; Wang H; Gullinello M; Shlomchik MJ; Putterman C
    J Neuroinflammation; 2016 Apr; 13(1):73. PubMed ID: 27055816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IgG4 Autoantibodies Attenuate Systemic Lupus Erythematosus Progression by Suppressing Complement Consumption and Inflammatory Cytokine Production.
    Pan Q; Xiao H; Shi L; He Y; Cai J; Wu J; Li A; Ye L; Yang C; Liu HF
    Front Immunol; 2020; 11():1047. PubMed ID: 32625200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Up-regulation of transcription factor Blimp1 in systemic lupus erythematosus.
    Luo J; Niu X; Liu H; Zhang M; Chen M; Deng S
    Mol Immunol; 2013 Dec; 56(4):574-82. PubMed ID: 23911415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Remission of systemic lupus erythematosus disease activity with regulatory cytokine interleukin (IL)-35 in Murphy Roths Large (MRL)/lpr mice.
    Cai Z; Wong CK; Dong J; Chu M; Jiao D; Kam NW; Lam CW; Tam LS
    Clin Exp Immunol; 2015 Aug; 181(2):253-66. PubMed ID: 25845911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Th17 and natural Treg cell population dynamics in systemic lupus erythematosus.
    Yang J; Chu Y; Yang X; Gao D; Zhu L; Yang X; Wan L; Li M
    Arthritis Rheum; 2009 May; 60(5):1472-83. PubMed ID: 19404966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferon regulatory factor 5 is critical for the development of lupus in MRL/lpr mice.
    Tada Y; Kondo S; Aoki S; Koarada S; Inoue H; Suematsu R; Ohta A; Mak TW; Nagasawa K
    Arthritis Rheum; 2011 Mar; 63(3):738-48. PubMed ID: 21305501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myeloid-derived suppressor cells contribute to systemic lupus erythaematosus by regulating differentiation of Th17 cells and Tregs.
    Ji J; Xu J; Zhao S; Liu F; Qi J; Song Y; Ren J; Wang T; Dou H; Hou Y
    Clin Sci (Lond); 2016 Aug; 130(16):1453-67. PubMed ID: 27231253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Depletion of autoreactive plasma cells and treatment of lupus nephritis in mice using CEP-33779, a novel, orally active, selective inhibitor of JAK2.
    Lu LD; Stump KL; Wallace NH; Dobrzanski P; Serdikoff C; Gingrich DE; Dugan BJ; Angeles TS; Albom MS; Mason JL; Ator MA; Dorsey BD; Ruggeri BA; Seavey MM
    J Immunol; 2011 Oct; 187(7):3840-53. PubMed ID: 21880982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of glutaminolysis ameliorates lupus by regulating T and B cell subsets and downregulating the mTOR/P70S6K/4EBP1 and NLRP3/caspase-1/IL-1β pathways in MRL/lpr mice.
    Zhang X; Wang G; Bi Y; Jiang Z; Wang X
    Int Immunopharmacol; 2022 Nov; 112():109133. PubMed ID: 36113317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of microRNA-448 suppresses CD4
    Zhang J; Guo Y; Sun Y; Chang L; Wang X
    Biochem Biophys Res Commun; 2022 Mar; 596():88-96. PubMed ID: 35121374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of (S)-armepavine from Nelumbo nucifera on autoimmune disease of MRL/MpJ-lpr/lpr mice.
    Liu CP; Tsai WJ; Shen CC; Lin YL; Liao JF; Chen CF; Kuo YC
    Eur J Pharmacol; 2006 Feb; 531(1-3):270-9. PubMed ID: 16413531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of B lymphocyte-induced maturation protein-1 reduces the production of autoantibody and alleviates symptoms of systemic lupus erythematosus.
    Luo J; Niu X; Zhang M; Zhang K; Chen M; Deng S
    Autoimmunity; 2015 Mar; 48(2):80-6. PubMed ID: 25347333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-ANX A1 Antibody Therapy in MRL/lpr Murine Model of Systemic Lupus Erythematosus.
    Bradyanova S; Mihaylova N; Chipinski P; Manassiev Y; Herbáth M; Kyurkchiev D; Prechl J; Tchorbanov AI
    Arch Immunol Ther Exp (Warsz); 2021 Jul; 69(1):19. PubMed ID: 34322760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversing interleukin-2 inhibition mediated by anti-double-stranded DNA autoantibody ameliorates glomerulonephritis in MRL-lpr/lpr mice.
    Song YC; Tang SJ; Lee TP; Hung WC; Lin SC; Tsai CY; Ng WV; Wu MF; Sun KH
    Arthritis Rheum; 2010 Aug; 62(8):2401-11. PubMed ID: 20506162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcium signaling in systemic lupus erythematosus T cells: a treatment target.
    Kyttaris VC; Zhang Z; Kampagianni O; Tsokos GC
    Arthritis Rheum; 2011 Jul; 63(7):2058-66. PubMed ID: 21437870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of FTY720 in MRL-lpr/lpr mice: therapeutic potential in systemic lupus erythematosus.
    Okazaki H; Hirata D; Kamimura T; Sato H; Iwamoto M; Yoshio T; Masuyama J; Fujimura A; Kobayashi E; Kano S; Minota S
    J Rheumatol; 2002 Apr; 29(4):707-16. PubMed ID: 11950011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD4(+)B220(+)TCRγδ(+) T cells produce IL-17 in lupus-prone MRL/lpr mice.
    Qiu F; Li T; Zhang K; Wan J; Qi X
    Int Immunopharmacol; 2016 Sep; 38():31-9. PubMed ID: 27235595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A benzenediamine derivative fc-99 attenuates lupus-like syndrome in MRL/lpr mice related to suppression of pDC activation.
    Ji J; Fan H; Li F; Li X; Dong G; Gong W; Song Y; Liu F; Hua C; Tan R; Dou H; Hou Y
    Immunol Lett; 2015 Dec; 168(2):355-65. PubMed ID: 26545567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondrial Dysfunction in the Liver and Antiphospholipid Antibody Production Precede Disease Onset and Respond to Rapamycin in Lupus-Prone Mice.
    Oaks Z; Winans T; Caza T; Fernandez D; Liu Y; Landas SK; Banki K; Perl A
    Arthritis Rheumatol; 2016 Nov; 68(11):2728-2739. PubMed ID: 27332042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.